- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05862519
A Clinical Study to Evaluate the Efficacy of Four Supplements on Improving Readiness for Intimacy
A Single-Group, Open-Label Clinical Study to Evaluate the Efficacy of Four Supplements on Improving Readiness for Intimacy
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Santa Monica, California, United States, 90404
- Citruslabs
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male (biological at birth) within the LGBTQIA+ community
- Aged between 18-44
- Generally healthy - don't live with any uncontrolled chronic disease
- Generally active lifestyle or seeking to achieve health improvement
- Sexually active with a partner
Exclusion Criteria:
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- Anyone with known severe allergic reactions.
- Unwilling to follow the study protocol.
- Currently experiencing significant symptoms of a mental disorder that might interfere with study participation (e.g. eating disorder, obsessive-compulsive disorder, posttraumatic stress syndrome, bipolar disorder)
- Current substance abuse disorder
- Diagnosis of an autoimmune disease, such as multiple sclerosis and rheumatoid arthritis
- Self-reported or diagnosed high blood pressure or hypotension (BP < 90 over 60)
- Currently, or in the past 6 months, undergoing hormone therapy
- Any medical condition that is unstable or uncontrolled
- A history of sexual trauma or abuse
- Has introduced any new prescription medication or supplements within the past 12 weeks that influence gastrointestinal issues, libido, or testosterone production.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
Participants will begin taking the Reset supplement for 5 days. Then there will be a 2-day break with no products taken (wash out period). Participants will then begin taking the following 2 supplements: Stay Ready Fiber and libido with a partial overlap of products. Stay Ready Fiber will be taken from day 7 through 21, three capsules will be taken twice daily in the morning and afternoon. Libido will be taken from day 7 through 28, 2 capsules will be taken daily, preferably with a meal. Participants will then begin taking the Testosterone supplement. Testosterone will be taken from day 28 through to 84, 2 capsules will be taken daily, preferably with a meal. |
Pure for Men Reset is a Vegan, Proprietary Blend of Toxin Eliminating Cleanser: Cascara Sagrada Bark, Senna Leaf, Psyllium Husk, Licorice Root, and Aloe Vera Gel.
Taken on Day 1 to Day 5.
Other Names:
Stay Ready Fiber is a Vegan, 100% Natural, Proprietary Blend of Digestive Aids: Psyllium Husk, Aloe Vera Extract, Chia Seeds & Flaxseed.
Taken from Day 7 through Day 21.
Other Names:
Supplement designed to support endurance and increased arousal.
Contains L-Citrulline, L-Arginine and Black Pepper Fruit Extract (Piper Nigrum).
Taken from Day 7 through to Day 28.
Other Names:
Supplement designed to enhance testosterone production.
Contains Ashwagandha, Zinc, Vitamin D, Maca, and Tongkat Ali.
Taken from Day 28 through Day 84.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in subject's perception of readiness and confidence for intimacy, and sex drive/arousal [Time Frame: Baseline to 12 weeks]
Time Frame: 12 weeks
|
Survey-based assessment (0-5 scale) of changes in reduction in preparation time for intimacy, sexual arousal, and sexual endurance.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in digestion, stamina and endurance during workouts, overall confidence, mood and quality of life [Time Frame: Baseline to 12 weeks]
Time Frame: 12 weeks
|
Survey-based assessment (0-5 scale) of changes in digestion, stamina and endurance during workouts, overall confidence, mood and quality of life.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20287
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Libido
-
BayerCompletedContraception | LibidoBelgium, Australia, Germany, Thailand, Spain, Austria, Italy
-
Applied Science & Performance InstituteCompletedSexual Health | LibidoUnited States
-
Bio Nature HealthCitruslabsCompletedLow Libido | Sexual; Desire AbsentUnited States
-
The University of Texas Health Science Center,...Not yet recruitingSexual Dysfunction | Menopause | Testosterone Deficiency | Libido DisorderUnited States
-
University Hospital Inselspital, BerneUniversity of Zurich; University Hospital MuensterCompletedPolymorphism, Genetic | Libido | Receptors, Androgen | Androgen EffectSwitzerland
-
Monash UniversityCompletedQuality of Life | Menopausal Syndrome | Libido DisorderAustralia
-
Radicle ScienceCompletedDepression | Fatigue | Anxiety | Menopause | Sleep Disturbance | Cognitive Function | LibidoUnited States
-
The University of Tennessee, KnoxvilleBreast Cancer Research FoundationCompletedSexual Dysfunction, Physiological | Body Image | Libido; Loss, AversionUnited States
-
TriHealth Inc.TriHealth Medical Education Research FundCompletedHypoactive Sexual Desire Disorder (HSDD) | Low Libido | Female Sexual Dysfunction (FSD)United States
Clinical Trials on Reset
-
Stanford UniversityNot yet recruiting
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPost-Traumatic Stress Disorder in Children | Post-Traumatic Stress Disorder in AdolescenceUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedObesity | Breast CancerUnited States
-
Morphic Medical Inc.Biostatistical Consulting, Inc.Recruiting
-
Stanford UniversityNot yet recruitingSpinal Cord Injuries | Spasticity, MuscleUnited States
-
Stanford UniversityEnrolling by invitationParkinson DiseaseUnited States
-
Stanford UniversityNot yet recruiting
-
Synergic Medical Technologies, Inc.Active, not recruitingParkinson's DiseaseUnited States
-
Indiana UniversityRichard L. Roudebush VA Medical CenterCompleted
-
Synergic Medical Technologies, Inc.Active, not recruitingParkinson DiseaseUnited States